Stay updated with breaking news from Nasdaq Cdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 2,170,000 shares, a decline of 30.0% from the February 28th total of 3,100,000 shares. Based on an average daily volume of 3,000,000 shares, the […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) was the recipient of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 2,170,000 shares, a decline of 30.0% from the February 28th total of 3,100,000 shares. Based on an average daily trading volume, of 3,000,000 shares, […]
Cidara Therapeutics (NASDAQ:CDTX – Get Rating) had its price objective reduced by HC Wainwright from $6.50 to $6.00 in a report released on Thursday morning, Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. Several other research analysts have also recently commented on CDTX. StockNews.com assumed coverage on Cidara Therapeutics in […]
Cidara Therapeutics (NASDAQ:CDTX – Get Rating) had its price target decreased by HC Wainwright from $6.50 to $6.00 in a report published on Thursday, Benzinga reports. HC Wainwright currently has a buy rating on the biotechnology company’s stock. Several other equities analysts have also issued reports on the company. Cantor Fitzgerald reiterated an overweight rating […]
A number of research firms have changed their ratings and price targets for Cidara Therapeutics (NASDAQ: CDTX): 6/6/2022 – Cidara Therapeutics is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 6/3/2022 – Cidara Therapeutics was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” […]